SlideShare a Scribd company logo
1 of 25
ALTERNATIVE METHODS
TO ANIMAL TOXICITY
TESTING
Saif Imtiyaz
M Pharm Pharmacology
Jamia Hamdard
PRESENTATION OUTLINES
1. Introduction…………………………………………….. 01- 02
2. The Rs Principles……………………………………… 03
3. Need For Alternatives To Animals…………………. 04
4. Alternative Methods…………………………...……… 05
5. Different alternative methods……………………….. 06- 22
6. References……………………………………………… 23
Introduction
● Animal models have been used to develop human biochemistry, physiology, pharmacology,
endocrinology, and toxicity. Every year, 10-100 million animals are used for testing.
● Animals used experimentation distributed among zebra- fish to primates. Vast majority of
animals are sacrificed at end of research programme.
● The use of animals can be further subdivided according to the degree of suffering
a. Minor animal suffering:- observing animals in behavioral studies, single blood sampling ,
immunization without adjuvants, etc.
b. Moderate animal suffering:- repeated blood sampling , recovery from general anesthesia ,
etc.
c. Severe animal suffering:- LD50% test , starvation vaccine potency tests, etc.
1
● Alternative methods to animals testing are the development and implementation of
test method that avoid use of live animals or use of less animals in method.
● The council directive on protection of animals used for experiments and scientific
purpose in Article 23
“The commission and member states should encourage research into
development and validation of alternative methods which could provide the
same level of information as that obtained in experiment using animals but
which involves less animal”.
2
The 5 R’s Principle
● Alternative methods able to do: Reduce Refine Replace ;
collectively called as “The 3Rs Principle”.
● The 3Rs principles were defined in 1959 by W.M.S Russel
and R.L Bruch. They provide a strategy for rational and
stepwise approach to minimizing animals use and
suffering in experiments without compromising the quality
and quantity of scientific work being undertaken.
● Reuse & Rehabilitate- The 4th & 5th R of Research implies
addition of ‘responsibility’ to the original three R’s, reflects
integrity, honesty, and scientific correctness in appropriate
and reasonable use of laboratory animals.
5 R’s
REDUCE
REHABILIT
ATE
REUSE
REPLACE
REFINE
3
Needs for Alternative Methods
Because in laboratory animals may be :
Poisoned
Deprived of food water and sleep
Applied with skin and eye irritants
Subjected to psychological stress
Deliberately infected with infected disease
Economic and efficiency
• Invitro testing human cell lines have been useful in securing relevant information for human risk
assessment thereby opening up opportunities to explore responses to existing and emerging
therapies human cell lines can be used for the tumor and some other chronic disease. 4
Alternative Techniques
● The term “alternative” is used to refer to those techniques or methods that replace the use of
laboratory animals altogether reduce the number of animals required or techniques to
minimize the level of stress endured by the animal.
● It is not possible to replace whole animal models with in vitro systems to evaluate drug effects
on major organ systems. However, techniques can greatly reduce the number of animals
needed, and refined protocols can improve the design efficiency and quality of studies,
and lessen stress and discomfort experienced by lab animals
● The field of alternative study particularly in vitro toxicology has evolved into a respected
discipline and is attracting competent and motivated scientist around the world.
5
Alternative to Animal Experiments
Continued but
modified use of
animals 5Rs
In vitro [test tube]
method
Tissue culture
technique
In silico
[computer
modelling
technique]
Computer aided molecular drug design [CADD]
Computer assisted learning [CAL]
Microfluidic chips
Quantitative structure activity relationship
Organ on chips
Computer or mathematic analysis
In silico
[computer
modelling
technique] 6
1. Continued But Modified Use Of Animals
Russel and Burch developed 3R’s strategy which include:
Refinement
• Refine
experimental
methods to
decrease
unnecessary
pain and
trauma to
animals.
Reduction
• Reduce the
no. of
animals used
in these
experiments
Replacement
• replace the
animal
experiments
e.g.
computer
stimulation
methods, In
vitro
methods,
Cell culture
techniques
7
Methods Of Refinement
 Providing relief [pain and distress] by giving drugs like analgesics,
anesthetics, tranquillizers and sedatives.
 By changing procedure
Modified to
reduce pain and
distress in
animal
Use non
invasive
technique like
MRI
Use less
sensitive animal
species
Use smaller
dose
Improving
housing
conditions
8
Methods Of Reduction
•Good planning of
studies Change in
experimental design
Improve methods of
data analysis
•Sharing research
animals
•Redesigning
studies to collect as
much information as
possible
•Share information.
9
Methods Of Replacement
Replace higher animals with lower animals
Replace live animals with dummies for teaching and
dissection purpose
ABSOLUTE REPLACEMENT: no need to use
animals e.g. cell lines, tissue of human or invertebrate
cell and tissue
RELATIVE REPLACEMENT: humane killing of
animals to provide cells or tissues for in vitro studies
Substitution of insentient material in place of
conscious higher animals
10
2. Invitro Models
11
• In vitro testing is the scientific analysis of the
effects of chemical substances on cultured
bacteria or mammalian cells, organ, tissues,
enzymes receptors enzymes.
• In vitro (literally 'in glass') testing methods are employed primarily : ̵ ̵ toidentify potentially
hazardous chemicals to confirm the lack of certain toxic properties in the early stages of the
development of potentially useful new substances such as therapeutic drugs, agricultural
chemicals and food additives.
• In vitro testing methods can be more useful and cost-effective than toxicology studies in
living animals (which are termed in vivo or "in life" methods).
Various Test In Vitro Methods
● In vitro pyrogen test
● Embryonic stem cell test
● Carcinogenicity test
● Neurotoxicity test
Avian chick embryo
Rodents[rat and mice, wild
type, transgenic , embryonic,
post natal , adult
Human cells [neural
progenitor cells from
aborted fetus and stem
cell lines]
Source Of Tissue For In Vitro Methods
12
3. Tissue Culture Techniques
● Tissue culture is in vitro maintenance and propagation of isolated cells, tissues or organs in
an appropriate artificial environment.
● APPLICATION OF ANIMAL CELL CULTURE
Toxicity
testing
Cancer
research
Virology Genetic
engineering
Gene
therapy
Drug
screening and
development
13
4. In silico [Computer Modelling] Techniques
● Without animal dissection computer generated stimulation are used to predict the
various possible biological and toxic effects of a chemical or potential drug candidate.
● VARIOUS TYPES IN SILICO MODELS
Computer aided molecular drug design [CADD]
Quantitative structure activity relationship
Computer assisted learning[CAL]
Computer or mathematical analysis
Organ on chips 14
A. Computer Aided Drug Design [CADD]
● It is the inventive process of finding new medications based
on the knowledge of a biological target.
● It involves the design of molecules that are complementary in
shape and charge to the biomolecular target with which they
interact and therefore will bind to it.
● It is used to predict the receptor binding site for a potential drug
molecule.
● CADD works to identify the probable binding site and hence
avoid testing of unwanted chemicals having no biological
activity. Computational approach to discover, develop and
analyze drugs.
15
● Drug design with the help of
computers may be used at any of the
following stages of drug discovery:
I. hit identification using virtual screening
(structure- or ligand-based design)
II. hit-to-lead optimization of affinity and
selectivity (structure-based design,
QSAR, etc.)
III. lead optimization: optimization of other
pharmaceutical properties while
maintaining affinity.
● Advantages of CADD
I. Time
II. Cost
III. Accuracy
IV. information about the disease
V. screening is reduced
VI. Database screening
VII. less manpower is required
16
Categories of software
Databases & Draw Tools
Molecular Modeling & Homology Modeling
Binding site prediction & Docking
Ligand design Screening -QSAR
Binding free energy estimation
ADME Toxicity 17
B. Quantitative Structure Activity Relationship
● A quantitative structure-activity relationship (QSAR) is a mathematical relationship which
correlates measurable or calculable molecular properties to some specific biological activity
in terms of an equation
● Computer programs which can predict the toxicity of new chemicals or drugs based on their
similarity to more established compounds. Principle that similar chemicals should have similar
biological properties.
● QSAR has been widely used in medicinal chemistry as support in drug’s discovery and
development process as well as in study of harmful and poisonous substances in
toxicological chemistry. QSAR attempts to find consistent relationship between biological
activity and molecular properties, so that these “rules” can be used to evaluate the activity of
new compounds
18
ADVANTAGES OF QSAR
● It gives quantifying the relationship between structure and activity with their physiochemical
property basis.
● Possible to make predictions of designed compounds before the chemical synthesis of novel
analogues.
● It may help to understand the interactions between functional group of designed molecules
and their activity of target enzyme or protein.
DISADVANTAGES OF QSAR
● Due to biological data experimental error it may give false correlations.
● If training set of molecule is less, the data may not reflect the complete property and it cannot
be used to predict the most active compounds.
● In some 3D QSAR study ligands binding receptor or protein may not be available
19
C. Organ On Chips
● It is a multichannel 3-D micro fluidic cell culture chip which simulates the activities,
mechanisms, physiological response of entire organs.
● These micro devices are translucent , they provide a window to watch inner workings of
human organs.
● Organ-on-chips that contain human cells grown in a state- of the-art system to mimic the
structure and function of human organ and organ system.
● The chips can be used instead of animals in disease research, drug testing and toxicity testing
and have been shown to replicate human physiology , diseases and drug responses more
accurately than crude animal experiments.
20
How will these organs on chips help the pharmaceutical
industries??
● Replace animal models.
● Help the laboratories reach the stage of clinical trials.
● Comparison studies of drugs on human and animals.
● To study the effect of drug on its main action of site and also other organs.
● Study of toxicity of drugs and cosmetics.
● To study about cancer cells and produce new drugs in cancer treatment.
● Ensure better regulatory decision-making.
● Develop vaccines and drugs to counter bioterrorism threats.
21
D. HET-CAM (Hen's egg-chorioallantoic membrane) TEST
● The fresh fertile white leghorn eggs are used.
● The eggs are held in optimized incubation condition.
● On day 10 inner egg membrane is removed , after careful removal the living vascular Chorio
Allantoic-Membrane is exposed.
● The test substance is dropped over CAM in a volume of 0.2- 0.3 ml and irrigated after 20 sec.
with 5ml warm water.
● The CAM, the blood vessels, including capillary system, and albumin are examined and
scored for irritant effects 0.5, 2, 5min after test compound application.
22
References
● Fundamentals of Experimental Pharmacology. M.N.Ghosh. 7th edition, 2020.
● Practical Manual of Pharmacology. Dinesh Badyal. 1st edition, 2021.
● Alternative Methods to Animal Experiments in Toxicity Testing. Nuhoğlu Öztürk, Zeyno
& Aksoy, Abdurrahman. 7th International Congress on Veterinary and Animal
Sciences (2022).
● Animal Use In Pharmacology Education And Research: The Changing Scenario.
Dinesh K. Badyal and Chetna Desai. Indian Journal of Pharmacology, May-June,
2014.
23

More Related Content

What's hot

Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationpradnya Jagtap
 
PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology Naveen K L
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesHimikaRathi
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).helasri gummadi
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testingpriyachhikara1
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxAnmolkanda06
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402Dr Ajay Mandal
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies Santosh Sai
 
Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies Dinesh Gangoda
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety PharmacologyPavana K A
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationShubhu20
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichAnimatedWorld
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicologyKhadga Raj
 
Safety pharmacology (siri)
Safety pharmacology (siri)Safety pharmacology (siri)
Safety pharmacology (siri)Ramavath Aruna
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422 SONALPANDE5
 
Alternative methods to animal testing: review
Alternative methods to animal testing: reviewAlternative methods to animal testing: review
Alternative methods to animal testing: reviewankit sharma
 
Aris G PHARMACOVIGILANCE AND VIGIFLOW
Aris G PHARMACOVIGILANCE AND VIGIFLOWAris G PHARMACOVIGILANCE AND VIGIFLOW
Aris G PHARMACOVIGILANCE AND VIGIFLOWayanarkumar19
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavKashikant Yadav
 

What's hot (20)

Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentization
 
PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402
 
REPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIESREPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIES
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies
 
Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety Pharmacology
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
 
Safety pharmacology (siri)
Safety pharmacology (siri)Safety pharmacology (siri)
Safety pharmacology (siri)
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
 
Alternative methods to animal testing: review
Alternative methods to animal testing: reviewAlternative methods to animal testing: review
Alternative methods to animal testing: review
 
Aris G PHARMACOVIGILANCE AND VIGIFLOW
Aris G PHARMACOVIGILANCE AND VIGIFLOWAris G PHARMACOVIGILANCE AND VIGIFLOW
Aris G PHARMACOVIGILANCE AND VIGIFLOW
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
 
Safety Pharmacology Studies ICH guideline S7A
Safety Pharmacology Studies ICH guideline S7ASafety Pharmacology Studies ICH guideline S7A
Safety Pharmacology Studies ICH guideline S7A
 

Similar to alternative methods of animal toxicity.pptx

Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testingSanchit Dhankhar
 
Alternative to animal toxicit testing.pptx
Alternative to animal toxicit testing.pptxAlternative to animal toxicit testing.pptx
Alternative to animal toxicit testing.pptxANANYAPANDEY71
 
Bioinformatic in drug designing
Bioinformatic in drug designingBioinformatic in drug designing
Bioinformatic in drug designingSalman Khan
 
ALTERNATIVES TO ANIMAL MODELS
ALTERNATIVES TO ANIMAL MODELSALTERNATIVES TO ANIMAL MODELS
ALTERNATIVES TO ANIMAL MODELSHarish Nakka
 
Alternative to invivo testing
Alternative to invivo testing Alternative to invivo testing
Alternative to invivo testing RuchithaRao2
 
Alternatives to animal experiments
Alternatives to animal experimentsAlternatives to animal experiments
Alternatives to animal experimentsRoopali Somani
 
Alternative to Animal Experimentation.pptx
Alternative to Animal Experimentation.pptxAlternative to Animal Experimentation.pptx
Alternative to Animal Experimentation.pptxAshwani Dhingra
 
Alternatives to animalexperiments.pptx
Alternatives to animalexperiments.pptxAlternatives to animalexperiments.pptx
Alternatives to animalexperiments.pptxDr.SIBI P ITTIYAVIRAH
 
Alternatives to animal testing
Alternatives to animal testingAlternatives to animal testing
Alternatives to animal testingGandla Sowmya
 
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICALEXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICALTMU
 
Role of bioinformatics of drug designing
Role of bioinformatics of drug designingRole of bioinformatics of drug designing
Role of bioinformatics of drug designingDr NEETHU ASOKAN
 
Alternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusainAlternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusainVasaya Mohammadhusain
 
drug discovery- history, evolution and stages
drug discovery- history, evolution and stagesdrug discovery- history, evolution and stages
drug discovery- history, evolution and stagesaiswarya thomas
 
Extrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxExtrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxARSHIKHANAM4
 
Bioinformatics role in Pharmaceutical industries
Bioinformatics role in Pharmaceutical industriesBioinformatics role in Pharmaceutical industries
Bioinformatics role in Pharmaceutical industriesMuzna Kashaf
 
Michael Festing - MedicReS World Congress 2011
Michael Festing - MedicReS World Congress 2011Michael Festing - MedicReS World Congress 2011
Michael Festing - MedicReS World Congress 2011MedicReS
 

Similar to alternative methods of animal toxicity.pptx (20)

Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
 
Alternative to animal toxicit testing.pptx
Alternative to animal toxicit testing.pptxAlternative to animal toxicit testing.pptx
Alternative to animal toxicit testing.pptx
 
Bioinformatic in drug designing
Bioinformatic in drug designingBioinformatic in drug designing
Bioinformatic in drug designing
 
ALTERNATIVES TO ANIMAL MODELS
ALTERNATIVES TO ANIMAL MODELSALTERNATIVES TO ANIMAL MODELS
ALTERNATIVES TO ANIMAL MODELS
 
Alternative to invivo testing
Alternative to invivo testing Alternative to invivo testing
Alternative to invivo testing
 
Alternatives to animal experiments
Alternatives to animal experimentsAlternatives to animal experiments
Alternatives to animal experiments
 
Methods of Research
Methods of Research Methods of Research
Methods of Research
 
Alternative to Animal Experimentation.pptx
Alternative to Animal Experimentation.pptxAlternative to Animal Experimentation.pptx
Alternative to Animal Experimentation.pptx
 
Alternatives to animalexperiments.pptx
Alternatives to animalexperiments.pptxAlternatives to animalexperiments.pptx
Alternatives to animalexperiments.pptx
 
Alternatives to animal testing
Alternatives to animal testingAlternatives to animal testing
Alternatives to animal testing
 
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICALEXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
 
Role of bioinformatics of drug designing
Role of bioinformatics of drug designingRole of bioinformatics of drug designing
Role of bioinformatics of drug designing
 
Alternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusainAlternatives to animal screening methods p'screening. mohammadhusain
Alternatives to animal screening methods p'screening. mohammadhusain
 
drug discovery- history, evolution and stages
drug discovery- history, evolution and stagesdrug discovery- history, evolution and stages
drug discovery- history, evolution and stages
 
Drug discovery
Drug discoveryDrug discovery
Drug discovery
 
Sparsh bioinfo.ppt
Sparsh bioinfo.pptSparsh bioinfo.ppt
Sparsh bioinfo.ppt
 
Extrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxExtrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptx
 
Bioinformatics role in Pharmaceutical industries
Bioinformatics role in Pharmaceutical industriesBioinformatics role in Pharmaceutical industries
Bioinformatics role in Pharmaceutical industries
 
Extrapolation.pptx
Extrapolation.pptxExtrapolation.pptx
Extrapolation.pptx
 
Michael Festing - MedicReS World Congress 2011
Michael Festing - MedicReS World Congress 2011Michael Festing - MedicReS World Congress 2011
Michael Festing - MedicReS World Congress 2011
 

More from ashharnomani

Protein microarray .pptx
Protein microarray .pptxProtein microarray .pptx
Protein microarray .pptxashharnomani
 
Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptxashharnomani
 
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptxMETHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptxashharnomani
 
Computational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptxComputational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptxashharnomani
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptxashharnomani
 
Oral contraceptives.pptx
Oral contraceptives.pptxOral contraceptives.pptx
Oral contraceptives.pptxashharnomani
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxashharnomani
 
Methods in Rational Drug design.pptx
Methods in Rational Drug design.pptxMethods in Rational Drug design.pptx
Methods in Rational Drug design.pptxashharnomani
 
pharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxpharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxashharnomani
 
Terminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptxTerminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptxashharnomani
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxashharnomani
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptxashharnomani
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxashharnomani
 
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxSPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxashharnomani
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptxashharnomani
 
antihelminthic.ppt
antihelminthic.pptantihelminthic.ppt
antihelminthic.pptashharnomani
 
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptxestablishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptxashharnomani
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxashharnomani
 

More from ashharnomani (20)

Protein microarray .pptx
Protein microarray .pptxProtein microarray .pptx
Protein microarray .pptx
 
Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptx
 
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptxMETHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
 
Computational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptxComputational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptx
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptx
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptx
 
Oral contraceptives.pptx
Oral contraceptives.pptxOral contraceptives.pptx
Oral contraceptives.pptx
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
 
Methods in Rational Drug design.pptx
Methods in Rational Drug design.pptxMethods in Rational Drug design.pptx
Methods in Rational Drug design.pptx
 
pharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxpharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptx
 
Terminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptxTerminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptx
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptx
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptx
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptx
 
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxSPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptx
 
GH RECEPTORS.pptx
GH RECEPTORS.pptxGH RECEPTORS.pptx
GH RECEPTORS.pptx
 
antihelminthic.ppt
antihelminthic.pptantihelminthic.ppt
antihelminthic.ppt
 
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptxestablishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptx
 

Recently uploaded

Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxUnboundStockton
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerunnathinaik
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 

Recently uploaded (20)

Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docx
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developer
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 

alternative methods of animal toxicity.pptx

  • 1. ALTERNATIVE METHODS TO ANIMAL TOXICITY TESTING Saif Imtiyaz M Pharm Pharmacology Jamia Hamdard
  • 2. PRESENTATION OUTLINES 1. Introduction…………………………………………….. 01- 02 2. The Rs Principles……………………………………… 03 3. Need For Alternatives To Animals…………………. 04 4. Alternative Methods…………………………...……… 05 5. Different alternative methods……………………….. 06- 22 6. References……………………………………………… 23
  • 3. Introduction ● Animal models have been used to develop human biochemistry, physiology, pharmacology, endocrinology, and toxicity. Every year, 10-100 million animals are used for testing. ● Animals used experimentation distributed among zebra- fish to primates. Vast majority of animals are sacrificed at end of research programme. ● The use of animals can be further subdivided according to the degree of suffering a. Minor animal suffering:- observing animals in behavioral studies, single blood sampling , immunization without adjuvants, etc. b. Moderate animal suffering:- repeated blood sampling , recovery from general anesthesia , etc. c. Severe animal suffering:- LD50% test , starvation vaccine potency tests, etc. 1
  • 4. ● Alternative methods to animals testing are the development and implementation of test method that avoid use of live animals or use of less animals in method. ● The council directive on protection of animals used for experiments and scientific purpose in Article 23 “The commission and member states should encourage research into development and validation of alternative methods which could provide the same level of information as that obtained in experiment using animals but which involves less animal”. 2
  • 5. The 5 R’s Principle ● Alternative methods able to do: Reduce Refine Replace ; collectively called as “The 3Rs Principle”. ● The 3Rs principles were defined in 1959 by W.M.S Russel and R.L Bruch. They provide a strategy for rational and stepwise approach to minimizing animals use and suffering in experiments without compromising the quality and quantity of scientific work being undertaken. ● Reuse & Rehabilitate- The 4th & 5th R of Research implies addition of ‘responsibility’ to the original three R’s, reflects integrity, honesty, and scientific correctness in appropriate and reasonable use of laboratory animals. 5 R’s REDUCE REHABILIT ATE REUSE REPLACE REFINE 3
  • 6. Needs for Alternative Methods Because in laboratory animals may be : Poisoned Deprived of food water and sleep Applied with skin and eye irritants Subjected to psychological stress Deliberately infected with infected disease Economic and efficiency • Invitro testing human cell lines have been useful in securing relevant information for human risk assessment thereby opening up opportunities to explore responses to existing and emerging therapies human cell lines can be used for the tumor and some other chronic disease. 4
  • 7. Alternative Techniques ● The term “alternative” is used to refer to those techniques or methods that replace the use of laboratory animals altogether reduce the number of animals required or techniques to minimize the level of stress endured by the animal. ● It is not possible to replace whole animal models with in vitro systems to evaluate drug effects on major organ systems. However, techniques can greatly reduce the number of animals needed, and refined protocols can improve the design efficiency and quality of studies, and lessen stress and discomfort experienced by lab animals ● The field of alternative study particularly in vitro toxicology has evolved into a respected discipline and is attracting competent and motivated scientist around the world. 5
  • 8. Alternative to Animal Experiments Continued but modified use of animals 5Rs In vitro [test tube] method Tissue culture technique In silico [computer modelling technique] Computer aided molecular drug design [CADD] Computer assisted learning [CAL] Microfluidic chips Quantitative structure activity relationship Organ on chips Computer or mathematic analysis In silico [computer modelling technique] 6
  • 9. 1. Continued But Modified Use Of Animals Russel and Burch developed 3R’s strategy which include: Refinement • Refine experimental methods to decrease unnecessary pain and trauma to animals. Reduction • Reduce the no. of animals used in these experiments Replacement • replace the animal experiments e.g. computer stimulation methods, In vitro methods, Cell culture techniques 7
  • 10. Methods Of Refinement  Providing relief [pain and distress] by giving drugs like analgesics, anesthetics, tranquillizers and sedatives.  By changing procedure Modified to reduce pain and distress in animal Use non invasive technique like MRI Use less sensitive animal species Use smaller dose Improving housing conditions 8
  • 11. Methods Of Reduction •Good planning of studies Change in experimental design Improve methods of data analysis •Sharing research animals •Redesigning studies to collect as much information as possible •Share information. 9
  • 12. Methods Of Replacement Replace higher animals with lower animals Replace live animals with dummies for teaching and dissection purpose ABSOLUTE REPLACEMENT: no need to use animals e.g. cell lines, tissue of human or invertebrate cell and tissue RELATIVE REPLACEMENT: humane killing of animals to provide cells or tissues for in vitro studies Substitution of insentient material in place of conscious higher animals 10
  • 13. 2. Invitro Models 11 • In vitro testing is the scientific analysis of the effects of chemical substances on cultured bacteria or mammalian cells, organ, tissues, enzymes receptors enzymes. • In vitro (literally 'in glass') testing methods are employed primarily : ̵ ̵ toidentify potentially hazardous chemicals to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives. • In vitro testing methods can be more useful and cost-effective than toxicology studies in living animals (which are termed in vivo or "in life" methods).
  • 14. Various Test In Vitro Methods ● In vitro pyrogen test ● Embryonic stem cell test ● Carcinogenicity test ● Neurotoxicity test Avian chick embryo Rodents[rat and mice, wild type, transgenic , embryonic, post natal , adult Human cells [neural progenitor cells from aborted fetus and stem cell lines] Source Of Tissue For In Vitro Methods 12
  • 15. 3. Tissue Culture Techniques ● Tissue culture is in vitro maintenance and propagation of isolated cells, tissues or organs in an appropriate artificial environment. ● APPLICATION OF ANIMAL CELL CULTURE Toxicity testing Cancer research Virology Genetic engineering Gene therapy Drug screening and development 13
  • 16. 4. In silico [Computer Modelling] Techniques ● Without animal dissection computer generated stimulation are used to predict the various possible biological and toxic effects of a chemical or potential drug candidate. ● VARIOUS TYPES IN SILICO MODELS Computer aided molecular drug design [CADD] Quantitative structure activity relationship Computer assisted learning[CAL] Computer or mathematical analysis Organ on chips 14
  • 17. A. Computer Aided Drug Design [CADD] ● It is the inventive process of finding new medications based on the knowledge of a biological target. ● It involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. ● It is used to predict the receptor binding site for a potential drug molecule. ● CADD works to identify the probable binding site and hence avoid testing of unwanted chemicals having no biological activity. Computational approach to discover, develop and analyze drugs. 15
  • 18. ● Drug design with the help of computers may be used at any of the following stages of drug discovery: I. hit identification using virtual screening (structure- or ligand-based design) II. hit-to-lead optimization of affinity and selectivity (structure-based design, QSAR, etc.) III. lead optimization: optimization of other pharmaceutical properties while maintaining affinity. ● Advantages of CADD I. Time II. Cost III. Accuracy IV. information about the disease V. screening is reduced VI. Database screening VII. less manpower is required 16
  • 19. Categories of software Databases & Draw Tools Molecular Modeling & Homology Modeling Binding site prediction & Docking Ligand design Screening -QSAR Binding free energy estimation ADME Toxicity 17
  • 20. B. Quantitative Structure Activity Relationship ● A quantitative structure-activity relationship (QSAR) is a mathematical relationship which correlates measurable or calculable molecular properties to some specific biological activity in terms of an equation ● Computer programs which can predict the toxicity of new chemicals or drugs based on their similarity to more established compounds. Principle that similar chemicals should have similar biological properties. ● QSAR has been widely used in medicinal chemistry as support in drug’s discovery and development process as well as in study of harmful and poisonous substances in toxicological chemistry. QSAR attempts to find consistent relationship between biological activity and molecular properties, so that these “rules” can be used to evaluate the activity of new compounds 18
  • 21. ADVANTAGES OF QSAR ● It gives quantifying the relationship between structure and activity with their physiochemical property basis. ● Possible to make predictions of designed compounds before the chemical synthesis of novel analogues. ● It may help to understand the interactions between functional group of designed molecules and their activity of target enzyme or protein. DISADVANTAGES OF QSAR ● Due to biological data experimental error it may give false correlations. ● If training set of molecule is less, the data may not reflect the complete property and it cannot be used to predict the most active compounds. ● In some 3D QSAR study ligands binding receptor or protein may not be available 19
  • 22. C. Organ On Chips ● It is a multichannel 3-D micro fluidic cell culture chip which simulates the activities, mechanisms, physiological response of entire organs. ● These micro devices are translucent , they provide a window to watch inner workings of human organs. ● Organ-on-chips that contain human cells grown in a state- of the-art system to mimic the structure and function of human organ and organ system. ● The chips can be used instead of animals in disease research, drug testing and toxicity testing and have been shown to replicate human physiology , diseases and drug responses more accurately than crude animal experiments. 20
  • 23. How will these organs on chips help the pharmaceutical industries?? ● Replace animal models. ● Help the laboratories reach the stage of clinical trials. ● Comparison studies of drugs on human and animals. ● To study the effect of drug on its main action of site and also other organs. ● Study of toxicity of drugs and cosmetics. ● To study about cancer cells and produce new drugs in cancer treatment. ● Ensure better regulatory decision-making. ● Develop vaccines and drugs to counter bioterrorism threats. 21
  • 24. D. HET-CAM (Hen's egg-chorioallantoic membrane) TEST ● The fresh fertile white leghorn eggs are used. ● The eggs are held in optimized incubation condition. ● On day 10 inner egg membrane is removed , after careful removal the living vascular Chorio Allantoic-Membrane is exposed. ● The test substance is dropped over CAM in a volume of 0.2- 0.3 ml and irrigated after 20 sec. with 5ml warm water. ● The CAM, the blood vessels, including capillary system, and albumin are examined and scored for irritant effects 0.5, 2, 5min after test compound application. 22
  • 25. References ● Fundamentals of Experimental Pharmacology. M.N.Ghosh. 7th edition, 2020. ● Practical Manual of Pharmacology. Dinesh Badyal. 1st edition, 2021. ● Alternative Methods to Animal Experiments in Toxicity Testing. Nuhoğlu Öztürk, Zeyno & Aksoy, Abdurrahman. 7th International Congress on Veterinary and Animal Sciences (2022). ● Animal Use In Pharmacology Education And Research: The Changing Scenario. Dinesh K. Badyal and Chetna Desai. Indian Journal of Pharmacology, May-June, 2014. 23